OnScale's Project BreathEasy features digital twins of lungs

Goal is to improve COVID-19 patient's outcomes.
April 15, 2020

OnScale announced Project BreathEasy, a consortium of multi-physics FEA/CFD vendors, medical-device manufacturers, engineers, and doctors from around the world who are developing digital twins of the lungs of COVID-19 patients to help doctors improve outcomes and optimize use of limited ventilator resources in major outbreak areas.

OnScale and LEXMA, a provider of advanced fluid-flow and biomechanical-simulation technology, have partnered to create patient-specific digital twins that may accurately predict oxygen and blood flow in a patient’s lungs, helping doctors make critical decisions about ventilator and intubation requirements for them.

Each digital twin is patient-specific and built from a combination of medical images (for example from CT scans and X-rays) and thousands of simulations of lung airflow and blood flow using the LEXMA Moebius fluid-dynamics solver running on OnScale’s Cloud Simulation platform. Digital twins are updated with real-time patient data. AI trained on simulated and measured patient data is used to make fast and accurate predictions of oxygen and blood flow throughout the ventilation and intubation process.

Sign up for Smart Industry Newsletters
Get the latest news and updates